Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eleven research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $129.33.
ADUS has been the topic of several research analyst reports. Raymond James Financial set a $137.00 price objective on Addus HomeCare in a research note on Monday, September 28th. Royal Bank Of Canada increased their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research note on Wednesday, August 5th. Bank of America restated a “neutral” rating and set a $125.00 price target (down from $140.00) on shares of Addus HomeCare in a report on Monday, September 14th. Weiss Ratings raised shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, September 24th. Finally, Barclays lifted their price target on shares of Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th.
Get Our Latest Research Report on Addus HomeCare
Addus HomeCare Price Performance
Shares of Addus HomeCare stock opened at $116.49 on Tuesday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.05. The stock has a market capitalization of $2.17 billion, a price-to-earnings ratio of 20.44, a price-to-earnings-growth ratio of 1.67 and a beta of 0.83. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $124.43. The company has a 50-day simple moving average of $116.48 and a two-hundred day simple moving average of $105.38.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a return on equity of 9.96% and a net margin of 7.13%. The business had revenue of $377.41 million for the quarter, compared to the consensus estimate of $376.24 million. During the same quarter in the prior year, the business posted $1.49 earnings per share. The firm’s quarterly revenue was up 8.0% compared to the same quarter last year. Analysts forecast that Addus HomeCare will post 6.30 EPS for the current year.
Hedge Funds Weigh In On Addus HomeCare
A number of institutional investors and hedge funds have recently modified their holdings of ADUS. NFJ Investment Group LLC bought a new stake in Addus HomeCare during the 2nd quarter valued at $29,000. Caitong International Asset Management Co. Ltd increased its holdings in Addus HomeCare by 73.8% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 325 shares of the company’s stock worth $35,000 after purchasing an additional 138 shares in the last quarter. Parallel Advisors LLC lifted its holdings in shares of Addus HomeCare by 66.3% in the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after purchasing an additional 161 shares in the last quarter. State of Wyoming purchased a new position in Addus HomeCare during the 2nd quarter worth $79,000. Finally, Persistent Asset Partners Ltd purchased a new stake in shares of Addus HomeCare in the second quarter valued at about $98,000. 95.35% of the stock is currently owned by institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation is a provider of home-based health care and support services for older adults, people with disabilities and other individuals who require assistance at home. The company’s services are designed to help clients maintain independence and avoid or delay institutional care.
Addus operates through three primary service lines: personal care, home health and hospice. Personal care services include assistance with daily activities such as bathing, dressing, meal preparation and mobility.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.
